Offer - Urjas Oil for just ₹ 1 X
Genotropin is a prescription drug, available for use as Injection. Primarily, it is used for the treatment of Acromegaly. Other than this, Genotropin has some other therapeutic uses, which have been discussed ahead.
The right dosage of Genotropin depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Genotropin include Upset stomach, Nausea or vomiting. Apart from the aforementioned side effects, Genotropin can also lead to other problems, which have been listed below. Normally, these side effects of Genotropin are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Genotropin has a Unknown effect for pregnant women and Unknown effect on lactating mothers. Further, the section on Genotropin related warnings talks about Genotropin's effects on the liver, heart and kidney.
Other contraindications of Genotropin have been discussed in the sections ahead.
Drug interactions for Genotropin have been reported in the medical literature. See below for a complete list.
You should also be aware that Genotropin is safe while driving, and is addiction.
Genotropin is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Genotropin safe for pregnant women?
No research has been done to ascertain the safety of Genotropin in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Genotropin safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Genotropin for breastfeeding women are not known.
What is the effect of Genotropin on the Kidneys?
Kidney can be affected by Genotropin. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Genotropin on the Liver?
Genotropin may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Genotropin on the Heart?
You may experience side effects on your heart after taking Genotropin. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Genotropin should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Genotropin unless your doctor advises you to do so -
Is this Genotropin habit forming or addictive?
Forming a habit of Genotropin has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Genotropin since it will not make you feel sleepy.
Is it safe?
Genotropin should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Genotropin cannot treat any kind of mental disorder.
Interaction between Food and Genotropin
There isn't any research available on the side effects of taking Genotropin with food.
Interaction between Alcohol and Genotropin
Information about the interaction of Genotropin and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Somatuline® (lanreotide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 237-238